CLINICAL_TRIALS
trial_result
· 2023-08-16
Clinical Trial Update: A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 clinical trial assessing EDP1815 for mild to severe atopic dermatitis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Evelo Biosciences, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-08-16